NAME DOSAGE DRU INDICAT CONTRAINDIC ADVE NURSING

OF , ROUTE, G ION ATION RSE CONSIDERA

DRUG AND ACTI EFFEC TIONS
FREQUE ON TS
NCY
Brand
Name:
Generic
Name:
Classifica
tion:

NAME DOSAGE DRUG INDICA CONTRAINDI ADVE NURSING

OF , ACTIO TION CATION RSE CONSIDERA
DRUG ROUTE, N EFFEC TIONS
AND TS
FREQUE
NCY
Brand Adult: Celecoxi  Acute Hypersensitivity  Abdo . Assessment
Name: Initially, b has and including those minal
400 mg COX-2 long- in whom attacks pain,  History:
Celecoxi followed by specific term of angioedema, diarrh Renal
b 200 mg if inhibitory treatme rhinitis and ea, impairment,
necessary activity. It nt of urticaria have nause impaired
Generic on the 1st inhibits signs been precipitated a, hearing,
Name: day. the and by aspirin, edem allergies,
Maintenan conversio sympto NSAIDs or a, hepatic and
celebrex ce: 200 mg n of ms of sulfonamides. dizzin CV
bid. arachido rheumat Severe hepatic ess, conditions,
Classific nic acid oid impairment; heada lactation,
ation: to arthritis severe heart che, pregnancy
NSAIDs, prostagla and failure; insom  Physical:
ndins osteoart inflammatory nia, Skin color
Analgesi while hritis bowel disease; upper
c and lesions;
having no  Reducti peptic ulcer; respir orientation,
effect on on of renal impairment atory reflexes,
the the pregnancy and tract ophthalmolog
formation number lactation. infecti ic and
of of ons; audiometric
prostagla colorect rash. evaluation,
ndins that al  Poten peripheral
mediate polyps tially sensation; P,
the in Fatal: edema; R,
normal familial Seriou adventitious
homeost adenom s skin sounds; liver
asis in atous reacti evaluation;
the GI polyposi ons CBC, LFTs,
tract, s (FAP) such renal function
kidneys  Manage as tests; serum
and ment of exfolia electrolytes
platelets acute tive
catalyzed pain derma Interventions
by COX-  Treatme titis,
1. nt of Steve
primary ns-  BLACK BOX
dysmen Johns WARNING:
orrhea on Be aware
syndr that patient
 Relief of
ome, may be at
signs
and increased
 and toxic
sympto epider risk for CV
ms of mal events, GI
anklylosi necrol bleeding;
ng ysis. monitor
spondyli accordingly.
tis  Administer
 Relief of drug with
signs food or after
and meals if GI
sympto upset occurs.
ms of  Establish
juvenile safety
rheumat measures if
oid CNS, visual
arthritis disturbances
occur.
 Arrange for
periodic
ophthalmolog
ic
examination
during long-
term therapy.
 WARNING: If
overdose
occurs,
institute
emergency
procedures—
gastric
lavage,
induction of
emesis,
supportive
therapy.
 Provide
further
comfort
measures to
reduce pain
(eg,
positioning,
environmenta
l control) and
to reduce
inflammation
(eg, warmth,
positioning,
and rest).

Teaching
points

 Take drug
with food or
meals if GI
upset occurs.
 Take only the
prescribed
dosage; do
not increase
dosage.
 You may
experience
these side
effects:
 Dizziness,
drowsiness
(avoid driving
or the use of
dangerous
machinery
while taking
this drug).
 Report sore
throat, fever,
rash, itching,
weight gain,
swelling in
ankles or
fingers;
changes in
vision.